Results 61 to 70 of about 940,148 (269)
ABSTRACT Background Central nervous system (CNS) inflammatory demyelinating syndromes, including multiple sclerosis (MS), aquaporin‐4 antibody–positive neuromyelitis optica spectrum disorder (AQP4 + NMOSD), and myelin oligodendrocyte glycoprotein (MOG) antibody–associated disease (MOGAD), occasionally overlap.
Bade Gulec +6 more
wiley +1 more source
On the nature of public policy
Based upon an analysis of different academic views on public policy, this article points out the deficiency of each, especially David Easton's view of "allocation of values." Through the analysis of solutions to public problems, this article concludes that the nature of public policy is government, which takes governmental interests and public ...
openaire +2 more sources
Early Clinical, Imaging, and Pathological Characteristics of SRPK3/TTN‐Digenic Myopathy
ABSTRACT Objective SRPK3/TTN‐digenic myopathy was recently established as a skeletal muscle myopathy caused by digenic inheritance. This study characterizes the early clinical presentation of SRPK3/TTN‐digenic myopathy in one previously reported and seven newly identified pediatric patients.
Rotem Orbach +23 more
wiley +1 more source
Advancing Stroke Clinical Trials Using Community Engagement and Implementation Science Approaches
ABSTRACT Stroke clinical trials are essential for advancing stroke care but can face challenges with recruitment, retention, clinical relevance, and translation into real‐world practice. We propose that integrating community engagement and implementation science approaches into stroke trials can help address these needs.
Lesli E. Skolarus +2 more
wiley +1 more source
ABSTRACT Objective Building on our prior Behavioral Risk Factor Surveillance System analysis identifying adults aged 18–39 as the primary driver of the national increase in self‐reported cognitive disability, we examined factors associated with this rise using 2013–2024 U.S. BRFSS data. Methods We analyzed U.S.
Adam de Havenon +9 more
wiley +1 more source
Vaccines and public policy [PDF]
My commitment to vaccines had its beginnings in an unlikely fashion. I just had completed two years of an internal medicine residency as well as two years of clinical and research training in infectious diseases at Vanderbilt University Medical Center in Nashville, Tennessee. Now it was time to fulfill my national service obligation (Selective Service--
openaire +2 more sources
Neurologic Manifestations of Long COVID Affect Adult Females More Severely Than Males
ABSTRACT Objective To characterize differences in neurologic manifestations of postacute sequelae of SARS‐CoV‐2 infection (Neuro‐PASC) between females and males. Methods Cross‐sectional study of the first consecutive 261 posthospitalization Neuro‐PASC (PNP) and 2068 nonhospitalized Neuro‐PASC (NNP) patients evaluated at the Neuro‐COVID clinic between ...
Hannah Kopinsky +5 more
wiley +1 more source
Methadone and Public Policy [PDF]
SummaryThis paper is written for the public health official of a city, state, county, municipality or other political entity faced with a heroin addiction problem which calls for a policy response. It identifies countries, cities or states which have a substantial experience with methadone. In some instances. New York City, for example, this experience
openaire +2 more sources
Crises in public policies are those unanticipated events or situations that disrupt ‘normal’ policy-making, threaten societal interests or values, and put extra pressure on decision-makers to resolve them with urgency. Crises constitute a major contemporary challenge for public policy: their multiplication challenges the effectiveness of regular policy
Cabane, L.D., Kuipers, S.L.
openaire +2 more sources
Vascular Disease, Non‐Steroidal Anti‐Inflammatory Drugs and Risk of Parkinson's Disease
ABSTRACT Objectives A history of vascular disease has been shown to be associated with an increased risk of Parkinson's disease, but this may be due to reverse causation. In addition, non‐steroidal anti‐inflammatory drugs are thought to reduce Parkinson's disease risk, but evidence is inconsistent and confounding by prior vascular disease is possible ...
Clare Wotton +4 more
wiley +1 more source

